Clinical trial
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
NCT00423878
Study timeline
Study start (unknown)2007-01-01Date precision: month
Registry last updated2016-11-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
RisperidoneDRUG · verified · RxNorm: risperidone
OlanzapineDRUG · verified · RxNorm: olanzapine
QuetiapineDRUG · verified · RxNorm: quetiapine
AripiprazoleDRUG · verified · RxNorm: aripiprazole
Sponsors & collaborators
National Institute of Mental Health (NIMH)lead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San AntonioTexas, United States1CincinnatiOhio, United States1MinneapolisMinnesota, United States1DetroitMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00423878 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.